FrontPage is India's Stock Market Social Network
Join 50,000+ Traders and Investors

KREBSBIO Share Price Discussion

Krebs Biochemicals & Industries Ltd.
Sector: Pharmaceuticals and health care
... Read more
KREBSBIO Share Price *
90 +0 (0%)
* (quote may be delayed)

Find answers to all your questions on live KREBSBIO message board: Is KREBSBIO buy or sell? Should I buy KREBSBIO shares? Why are KREBSBIO shares falling? Should I invest in KREBSBIO stock?

KREBSBIO Discussion Forum

  • KREBSBIO - Share Price - Fundamentals

    Market Capitalization192.91
    Enterprise Value225.82
    Price to Earnings13.38
    Price to Book Value93.58
    Return on Capital Employed-0.33
    Return on Equity1
    Face Value10
    Dividend YieldNA
  • KREBSBIO Share Price - Technicals

    KREBSBIO - 52 Week High₹135
    KREBSBIO - 52 Week Low₹61.95
  • KREBSBIO Share Price - Historical (₹)

    Dec 994.994.983.690.1
    Dec 683.393.283.390
    Dec 585.492.685.487.35
    Dec 490.1590.1585.1588.5
    Dec 391.693.986.693.4
  • KREBSBIO Share Price - Daily Moving Averages (DMA)

    20 Day Moving Average₹89.89
    30 Day Moving Average₹90.66
    50 Day Moving Average₹88.89
    100 Day Moving Average₹83.15
    200 Day Moving Average₹88.33
  • KREBSBIO - Profit And Loss

    CONSOLIDATEDMar-18Mar-17 % Change
    Operating Profit-8.86-8.80.01
    Profit Before Tax-17.83-16.050.11
    Net Income-17.82-16.050.11
  • KREBSBIO - Balance Sheet

    CONSOLIDATEDMar-19Mar-18 % Change
    Shareholder's Funds-14.29-17.78-0.2
    Total Liabilities156.66143.660.09
    Total Assets142.37125.880.13
  • KREBSBIO - Cash Flow

    CONSOLIDATEDMar-18Mar-17 % Change
    Cash from Operating Activity-7.15-11.2-0.36
    Cash from Investing Activity-1.48-4.7-0.69
    Cash from Financing Activity8.9315.75-0.43
    Net Cash Flow0.3-0.15-3
  • KREBSBIO - Ratios

    Return on Assets-0.14-0.13
    Return on Equity1-10.92
    Return on Capital Employed-0.33-0.26
  • KREBSBIO - 3 year Growth

    3 Year CAGR Growth in Revenue-0.99
    3 Year CAGR Growth in Operating Profit-3.54
    3 Year CAGR Growth in EBIDTA-3.38
    3 Year CAGR Growth in Net Income-1.27
    3 Yr CAGR Growth - Diluted EPS-0.57
  • KREBSBIO - 5 year Growth

    5 Year CAGR Growth in Revenue1.95
    5 Year CAGR Growth in Operating Profit0.33
    5 Year CAGR Growth in EBIDTA-0.21
    5 Year CAGR Growth in Net Income-0.17
    3 Yr CAGR Growth - Diluted EPS0.19
  • KREBSBIO - Recent News

  • KREBSBIO - Related Communities

    Wanbury Ltd. Sector: Pharmaceuticals ...
    Piramal Phytocare Ltd. Sector: Pharma...
    Parabolic Drugs Ltd. Sector: Pharmace...
    Orchid Pharma Ltd. Sector: Pharmaceut...
    Biofil Chemicals & Pharmaceuticals Lt...
    Wockhardt Ltd. Sector: Pharmaceutical...
    Vivimed Labs Ltd. Sector: Pharmaceuti...
    Venus Remedies Ltd. Sector: Pharmaceu...
    Unichem Laboratories Ltd. Sector: Pha...
    TTK Healthcare Ltd. Sector: Pharmaceu...
SOURCE: Data from D'Market via Quandl. Intraday data delayed 15 minutes.
DISCLAIMER: Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.